NOVAVAX INC — Director's Dealing 2021

Aug 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2021-08-19

Reporting Person: Trizzino John (EVP, CCO and CBO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-19	Restricted Stock Units	$	A	1965	Acquired		Common Stock (1965)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.

F2: This grant was made under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), in recognition of services rendered by the Reporting Person as Interim Chief Financial Officer of the Company. One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the August 19, 2021 grant date, subject to continued employment through each such vesting date.